Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

February 21, 2006 Approval Letter - Havrix

Public Health Service
Food and Drug Administration
1401 Rockville Pike
Rockville MD 20852-­1448

February 21, 2006

Our STN: BL 103475/5100

GlaxoSmithKline Biologicals
Attn: Ms. Judith Magner
2301 Renaissance Boulevard
P.O. Box 61540
King of Prussia, PA 19406-2772

Dear Ms. Magner:

We have approved your request to supplement your biologics license application for Hepatitis A Vaccine Inactivated to include the package insert labeling changes regarding geriatric use.

We will include information contained in the above-referenced supplement in your biologics license application file.

Please submit all final printed labeling at the time of use and include implementation information on FDA Form 356h. Please provide a PDF-format electronic copy as well as one original paper copy.

Sincerely yours,

--- signature ---

Karen L. Goldenthal, M.D.
Division of Vaccines and Related Products Applications
Office of Vaccines Research and Review
Center for Biologics Evaluation and Research


Return to product page

Resources for You

Page Last Updated: 07/14/2009
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English